Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 5;2:1–8. doi: 10.1016/j.urine.2021.02.001

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 1 — Proteomics study on urine samples of COVID-19 patients. (A) Basic information and clinical symptoms of COVID-19 patients, including mild (n = 3) and severe (n = 3) patients. No.4 patient (P4) was with multiple metastases of colon cancer and died on March 3, 2020. No.1 (P1) and 6 (P6) patients labeled with asterisk indicated the persons providing the recovery urine samples. cRNA indicated that the SARS-CoV-2 nucleic acid. (B) Ground-glass opacity on Computed Tomography (CT) of COVID-19 patients. (C) The amounts of IL-6 between mild and severe COVID-19 patients. (D) Experimental design of urine proteomics for COVID-19 patients. Interleukin-6, IL-6.